S.Biomedics Repurchases KRW 300 Million in Convertible Bonds Before Maturity

PUBT · 1d ago
S.Biomedics Repurchases KRW 300 Million in Convertible Bonds Before Maturity
  • S.Biomedics repurchased KRW 300 million of convertible bonds for KRW 309.12 million on Nov. 13, 2026.
  • Bondholders exercised put options on the bonds, which mature Nov. 13, 2029.
  • The repurchase left KRW 945 million outstanding. The acquired bonds will be resold or canceled, pending a decision.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. S.Biomedics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261113901433), on November 13, 2026, and is solely responsible for the information contained therein.